| Jon Haynes, MD | |
|
2315 Stockton Blvd, Sacramento, CA 95817 | |
| (916) 734-8570 | |
| (916) 734-7950 |
| Full Name | Jon Haynes |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 2315 Stockton Blvd, Sacramento, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023404498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A145049 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health And Rideout | Marysville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
| Entity Name | San Francisco Physicians International Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841220720 PECOS PAC ID: 5597679225 Enrollment ID: O20031117000934 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
| Entity Name | Solano Gateway Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952344293 PECOS PAC ID: 5496725418 Enrollment ID: O20040916001355 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jon Haynes, MD 2315 Stockton Blvd, Sacramento, CA 95817-2201 Ph: (916) 734-8570 | Jon Haynes, MD 2315 Stockton Blvd, Sacramento, CA 95817 Ph: (916) 734-8570 |
News Archive
Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.
› Verified 2 days ago
Elizabeth Johnson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 | |
Timothy Sturgill, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Hospital Dr, Sacramento, CA 95823 Phone: 330-493-4443 | |
Mark Portman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd., Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Juliette Gerardo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-2011 | |
Dr. John Ray Richards, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Pssb 2100 Emergency Medicine, Sacramento, CA 95817 Phone: 916-734-1537 Fax: 916-734-7950 | |
Kerilee Wenker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2801 L St, Sacramento, CA 95816 Phone: 916-454-2222 |